Completed PHASE2 INTERVENTIONAL 2-arm NCT01913470

Study of Losartan in the Treatment of NAFLD in Children

A Pilot Study of Losartan in the Treatment of Pediatric NAFLD

Sponsor: Children's Healthcare of Atlanta

Conditions NAFLD

Interventions Losartan

Updated 7 times since 2017 Last updated: Apr 6, 2017 Started: Jul 31, 2013 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on NAFLD, this trial is completed. The trial is conducted by Children's Healthcare of Atlanta and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jul 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jul 2017 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Healthcare of Atlanta
Miriam Vos, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Data source: Emory University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Atlanta, United States